Cancers, Free Full-Text

Overexpression of Exportin-1 (XPO1), a key regulator of nuclear-to-cytoplasmic transport, is associated with inferior patient outcomes across a range of adult malignancies. Targeting XPO1 with selinexor has demonstrated promising results in clinical trials, leading to FDA approval of its use for multiple relapsed/refractory cancers. However, XPO1 biology and selinexor sensitivity in childhood cancer is only recently being explored. In this review, we will focus on the differential biology of childhood and adult cancers as it relates to XPO1 and key cargo proteins. We will further explore the current state of pre-clinical and clinical development of XPO1 inhibitors in childhood cancers. Finally, we will outline potentially promising future therapeutic strategies for, as well as potential challenges to, integrating XPO1 inhibition to improve outcomes for children with cancer.

The role of free-fatty acid receptor-4 (FFA4) in human cancers and

National Comprehensive Cancer Network - Home

𝓙𝓾𝓵𝓲𝓪𝓷𝓮_𝓛𝓲𝓫𝓮𝓻𝓽𝓸 (@JulianeLiberto) / X

Home - Free ME from Lung Cancer

Cancer treatment and survivorship statistics, 2022 - Miller - 2022

Loco Evolution Binary Patch - Colaboratory

Cancers, Free Full-Text

CA: A Cancer Journal for Clinicians - Wiley Online Library

Noninvasive detection of any-stage cancer using free

Quantitative estimates of preventable and treatable deaths from 36

Download or order free information booklets

Loco Evolution Binary Patch - Colaboratory

Cancers, Free Full-Text

O Amar Mota Bou Get File - Colaboratory

Know the signs of cancer to catch it early